How To Comment (1 of 2)

NOTE: FDA will consider only those comments submitted during an open comment period

• Submit written comments to:
  
  Dockets Management Branch (HFA-305)
  Food and Drug Administration
  5630 Fishers Lane, rm. 1061
  Rockville, MD USA 20852